T. Rowe Price Investment Management, Inc. Applied Therapeutics Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 10,380,590 shares of APLT stock, worth $4.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,380,590
Previous 5,420,920
91.49%
Holding current value
$4.26 Million
Previous $4.64 Million
9.35%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.72 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.63 Million6.41% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.2 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.41 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $19.7M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...